Compositions and methods for reducing major thrombotic events in cancer patients
US11872241B2 · kind B2 · utility
2Cited by
40References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 26, 2019 |
| Grant date | Jan 16, 2024 |
| Priority date | — |
| Expiry date | Nov 26, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods for reducing soluble P-selectin and major thrombotic events in cancer patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.